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IntrOductIOn
Beta-thalassaemia major is an inherited, autosomal disorder due to 
point mutation or, in very rare cases, beta-globin gene deletion on 
chromosome 11, which leads to decrease in or lack of beta-globin 
sequence. Ineffective erythropoiesis in beta-thalassaemia is due to 
defective synthesis of haemoglobin and causes turnover increase 
in red blood cells (RBCs). A 2-3 units of blood are transfused 
per 4-6 weeks based on the patient’s condition and the ability to 
maintain a blood haemoglobin concentration over 10. Iron chelation 
therapy is usually commenced after 10-15 transfusion turns and 
through control of ferritin level, and the most common method is 
subcutaneous infusion of desferrioxamine. The complications due 
to iron overload include endocrine complications, developmental 
disorders, deficiency in sexual puberty, diabetes mellitus, etc. In 
addition, heart disease due to iron overload is the most prevalent 
cause of mortality in the patients. Treatment by a regular program of 
blood transfusion and iron chelation leads to decrease in iron overload 
and increase in life expectancy. However, treatment complications 
are still high and affect the quality of life [1]. Thalassaemia has been 
reported as the most common single gene disorder in Iran with the 
prevalence up to 10% [2]. 
Immunosenescence is considered as a complex process that 
negatively affects the development of the immune system and 
lymphocytes’ function. This process occurs naturally as age 
advances, but could develop early in young people due to a 
variety of chronic inflammations, infections, and neoplastic 
conditions [3]. Oxidative damage is a main factor of accelerating 
immunosenescence. In fact, stress results in early ageing 
because of damaging DNA and hence shortening telomeres 
[4]. Several findings confirm the presence of oxidative condition 
in the patients with beta-thalassaemia [5], which could lead to 
early immunosenescence. Regular blood transfusion causes 
immunosenescence to be accelerated via immuno-suppression 
and transmission of viruses with immunosuppressive characteristics 
like cytomegalovirus, hepatitis C virus and Epstein-Barr virus [6].
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ABStrAct
Introduction: Oxidative damage and regular antigenic stimulation 
are main factors in accelerating immunosenescence. The present 
study was conducted to investigate new concepts of early 
immunosenescence in thalassaemia patients. 
Materials and Methods: Twenty seven beta-thalassaemia major 
patients and a group of matched healthy volunteers aged 10-30 
years in Shahrekord, Iran were recruited into the study. Ferritin 
level was determined and CD4 or CD8 T cells were analysed 
versus phenotyping markers, CD27, CD28, CD57 and CCR7, 
by flowcytometry. Data were analysed by Mann-Whitney and 
Spearman’s correlation coefficient test in SPSS 11.5. 
results: Absolute lymphocytosis and partial decrease in T cells 
were observed in the patients. CD4+CD57+ and CD4+CCR7- 
T cells were significantly higher, whereas CD8+CD27+ and 
CD8+CCR7+ T cells were partially higher in patients. A negative 
correlation was observed between ferritin level and number of 
CD8+CD27+ and CD8+CCR7+ T cells, whereas the correlation 
was positive between ferritin level and number of CD57+ T cells. 
conclusion: Moderate alteration of T cell repertoire and increase 
in CCR27-, CCR7-, and CD57+ T cells could reflect antigenic 
stimulation, decline in naïve T cells, and being closer to terminally 
differentiated cells. Effect of iron overload is potentially explained 
by positive correlation of blood transfusion and ferritin level with 
frequency of CD3+CD27- and that of ferritin with frequency of 
CD57+ T cells.
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Continuous antigenic stimulation could decline the cells’ ability to 
transcribe and turn them into aged cells. Repeated blood transfusion 
and haemolysis could be the reasons for producing free radicals and 
oxidative conditions [5]. Splenectomy in addition to immune paralysis 
against encapsulated bacteria brings about some changes in 
lymphocytes [7]. This alteration leads to exacerbating the effects of 
repeated blood transfusion on immune system. Immunosenescence 
is accompanied with a pronounced decline in naïve lymphocytes’ 
population which is caused by construction decline in T cells. T 
cell-mediated immunity depends on the predominance of paticular 
subsets. One of the most common signs of age-related changes 
is accumulation of CD28-CD8+ T cells, which could be due to 
continuous antigenic stimulation of CD28+CD8+T cells. In fact, 
clonal expansion of CD28- lymphocytes seems to be responsible 
for increase in infection and failure to respond to vaccines [8].
The available data ragarding the CD+CD28-CD57+ T cell subsets 
and immunoscenescence are inconsistent. Expression of CD57 on T 
cells and NK cells is supposed to be a marker of proliferation inability 
and short telomeres [9]. While many studies have demonstrated 
that CD28- and CD57+ T cells lose their proliferative capacity, some 
others have found that these cells can upregulate this capacity 
under certain stimulation conditions [10].
Gradual decline in responsiveness to antigens is due to immuno-
senescence and T lymphocytes ageing, and resulted abnormal 
function leads to T cell-associated immunosuppression. T cells 
immunosenescence has been confirmed by some characteristics 
such as failure of CD27 gene expression, telomeres shortening, 
failure of proliferation, resistance to apoptosis and selective decrease 
in pro-inflammatory receptors [11,12].
CCR7 is a chemokine receptor that controls homing to lymph nodes 
and divides memory T cells into two subsets. CCR7+ memory T 
cells have no immediate effector function, but stimulate dendritic 
cells efficiently and differentiate to CCR7- T cells after secondary 
stimulation. CCR7- T cells have exhibited immediate effector 
function [13]. 
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The infection in thalassaemia patients is prevalent and one of the 
reasons for death in most patients. The reason for this increased 
predisposition is not clear in some cases. Since recent studies 
have indicated immunosuppression and some dimensions of 
early immunosenescence in the patients with beta-thalassaemia 
major [5,14,15], and stupendous treatment costs are imposed on 
the patients with this disease, the present study was conducted 
to investigate new concepts of early immunosenescence in the 
patients with beta-thalassaemia major and to identify immunologic 
complications relevant to the disease and its treatment to develop 
approaches to prevention of immunologic disorders and to increase 
life expectancy in these patients.
MAterIAlS And MethOdS 
Patients and controls
This case-control, cross-sectional study was conducted on 27 
patients with beta-thalassaemia major referring Hajar Hospital of 
Shahrekord, Iran between October 2012 and December 2013 with 
mean age of 17.07±5.02 (range: 10-30) years. Of the patients, 63% 
were male. A control group of 26 healthy subjects (with mean age 
of 19.6 ± 6.1 years) matched by age, of whom 57.7% were male, 
were recruited from local volunteers. Patients entered into the study 
if they had diagnostic criteria of beta-thalassemia major and were 
10-30 years old. The exclusion criteria were hepatitis B and C and 
HIV positivity, chelation therapy except desferrioxamine, infection 
within the past three weeks, pregnancy and taking vitamin C or 
folic acid within the past 48 hours. A checklist containing patients’ 
information consisting of age, gender, records number, the time of 
disease diagnosis, total number of blood transfusion, transfusion 
intervals, volume of transfused blood in each referring, haemoglobin 
and ferritin levels, splenecotmy, and treatment with desferrioxamine 
was filled out. After informed consent was obtained, venous blood 
was collected in three tubes containing EDTA, sodium heparin, and 
no anti-coagulant. 
Measurement of hematologic Indices and Ferritin
Blood count was measured by EDTA blood sample and automated 
cell counter (Sysmex KX21, Sysmex Corporation, Japan). Serum 
samples were separated and ferritin level was measured by ELISA 
(Orgentec Kit, Germany).
Investigation of Biomarkers cd57, cd28, cd27  
and ccr7
The phenotyping was performed with sodium heparin containing 
blood, and RBCs were lysed by ammonium chloride buffer. Then, the 
cells were kept in complete culture media. The cells were incubated 
with directly conjugated monochlonal antibodies in 4ºC and 
darkness. Each combination included anti-CD3PE, anti-CD4APC 
or anti-CD8 PE-CY5 and one of the phenotyping antibodies; anti-
CD27, anti-CD28, anti-CD57 and anti-CCR7 FITC. After incubation, 
the cells were washed, fixed in paraformaldehyde, and kept at 4ºC 
and darkness until flow cytometric analysis.
Flow cytometry
Flow cytometric analysis was performed on a flow cytometer 
(PARTEC, Germany). 2×104 - 5×104 cells were collected, and 
lymphocytes were gated by FSC versus SSC, and then CD3+ cells 
were gated versus SSC. Data were analysed using flowmax 2.4 
software and displayed as dot plots of CD4 or CD8 versus other 
phenotyping markers. The expression of each individual marker was 
analysed versus CD4 or CD8. The absolute number was calculated 
by flow cytometric data and the cell counts.
Monoclonal Antibodies
The following monoclonal antibodies were purchased from Beckton-
Dickinson Immunocytometry System, USA and used in the study: 
Anti-CD57FITC, anti-CD3PE, anti-CD8PE-Cy5, anti-CD4APC, anti-
CCR7FITC, anti-CD28FITC, anti-CD27FITC and mouse IgG1 and 
IgG2a.
StAtIStIcAl AnAlySIS
The data on complete blood count, flow cytometric data, and the 
data obtained from other laboratory tests and clinical findings were 
analysed by Mann-Whitney and Spearman’s correlation coefficient 
test in SPSS 11.5.
reSultS
considerable lymphocytosis, but lower t cell count 
in Beta-thalassaemia Major 
Transfusion interval was 3.2 ± 0.3 weeks, serum ferritin 1529.3 ± 
954.8 ng/ml, and desferal infusion level 5.2 ± 0.8 nights per week.
White blood cell count was higher in the patients (8723.5 ± 8594.10 
/ mm3) than the control group (5134.13 ± 818.98 / mm3), with no 
statistically significant difference.
A notable lymphocytosis was observed in the patients compared 
to the control group (p < 0.001). On the other hand, the proportion 
of T lymphocytes in the patients (28.63 ± 24.02%) decreased 
significantly compared to the control group (54.81 ± 14.87%) (p 
< 0.001). However, the number of T lymphocytes did not change 
significantly in the patients compared to the control group. The 
proportion and absolute number of CD4+ and CD8+ T cells in the 
patients did not change significantly compared to the control [Table/
Fig-1].
Increased lymphocyte count and decreased t cell 
count in Splenectomized Patients
As shown in [Table/Fig-2], a considerable lymphocytosis was 
observed in the splenectomized group (10674.2 ± 10403.5 /mm3) 
compared to the unsplenctomized (2747 ± 994.96/mm3) (p < 
0.001). However, CD3+ T cells count and frequency were higher in 
the unsplenectomized patients.
Altered expression of cd27, cd57, and ccr7 on 
Patients t cells
The frequency of T cells expressing each phenotyping marker was 
investigated [Table/Fig-3]. 
Parameters Patients (27) Controls (26) p-value
Mean±SD
WBC count/mm3 8723.5 ±8594.10 5134.13±818.89 NS
Lymphocyte count/mm3 7984.22 4±620 2122.21±543.7 < 0.001
CD3+ T cells (%) 28.63±24.02 54.8±14.87 < 0.001
CD3+ T cells count/mm3 992.29±582.81 1216.29±458.33 NS
CD4+ T cell/mm3 576.73±45.13 644.15±294.5 NS
CD8+ T cell/mm3 405.35±201.17 417.04±155.44 NS
[table/Fig-1]: Immunologic parameters in the patients compared to the control.
NS: Not significant
Parameters
Splenectomized 
(12)
un-
splenectomized 
(15) p-value
Mean±SD
WBC count/mm3 13609±11499.4 4626.8±1011 < 0.001
Lymphocyte (%) 74.41±13.07 59.48±16.76 0.019
Lymphocyte count/mm3 10674.3 ± 10403 2747.5±994.96 < 0.001
CD3+cells /mm3 828.3±676.01 1123.4±465.86 0.043
CD3+cells (%) 9.91±9.36 43.66±21.39 < 0.001
CD4+ T cell/mm3 513.8±378.1 648.8±310.4 NS
[table/Fig-2]: Subpopulations of lymphocytes in splenectomized patients with 
beta-thalassaemia major compared to the unspelenectomized.
NS: Not significant
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[table/Fig-3]: Expression of phenotypic markers on peripheral blood CD4+ T cells of a representative sample from beta-thalassaemia patients and healthy controls; the 
expression of each individual marker was analysed versus CD4. The percentages represent the proportion of CD4+ T cells expressing each phenotypic marker.
Parameters patients controls p-value
mean±SD
CD4+ t cells
CD27 275.71±196.45 476.95±255.33 0.079
CD28 314.53±197.33 477.64±269.65 NS
CD57 260.64±168.26 117.27±67.28 0.009
CCR7 141.08±96.72 306.40±232.33 0.027
CD8+ t cells
CD27 236.83±160.69 298.68±119.34 NS
CD28 181.22±112.30 256.93±123.96 NS
CD57 204.14±160.50 83.15±64.01 0.059
CCR7 273.69 ±203.23 156.22±102/04 NS
[table/Fig-4]: Comparison of the frequency of cells expressing each one of 
phenotypic markers on CD4+ and CD8+ T cells between the control group and the 
patients.
type of 
lymphocyte age
Ferritin 
level
transfusion 
level
Desferal 
consumption
CD3+
Correlation 
coefficient
-0.27 0.14 -0.29 -0.11
p-value NS NS NS NS
CD3+CD4+CD27+
Correlation 
coefficient
-0.22 -0.38 -0.11 -0.16
p-value NS NS NS NS
CD3+CD8+CD27+
Correlation 
coefficient
-0.44 -0.75 -0.62 -0.25
p-value NS 0.01 0.04 NS
CD3+CD4+CD57+
Correlation 
coefficient
0.014 0.85 0.018 0.35
p-value NS 0.002 NS NS
CD3+CD8+CD57+
Correlation 
coefficient
-0.25 0.75 -0.16 0.45
p-value NS 0.003 NS NS
CD3+CD4+CCR7+
Correlation 
coefficient
-0.053 0.31 0.091 0.21
p-value NS NS NS NS
CD3+CD8+CCR7+
Correlation 
coefficient
- 0.35 - 0.70 -0.014 0.26
p-value NS 0.025 NS NS
CD3+CD4+CD28+
Correlation 
coefficient
-0.024 0.53 -0.068 0.48
p-value NS NS NS NS
CD3+CD8+CD28+
Correlation 
coefficient
-0.051 0.39 0.091 0.68
p-value NS NS NS 0.03
[table/Fig-5]: Correlation of the frequency of T lymphocytes expressing each 
phenotypic marker with the patients’ age, ferritin level, desferal infusion, and the 
number of blood units consumed by the patients.
There was a tendency toward decreasing the number of 
CD3+CD4+CD27+ T cells in the patients (p=0.07). The number of 
CD3+CD8+CD27+ lymphocytes in the patients was not significantly 
different from that in the control group [Table/Fig-4]. 
No significant difference was observed in the number of 
CD3+CD4+CD28+ and CD3+CD8 +CD28+ between the patients 
and the control group. The number of CD3+CD4+CD57+ in the 
patients was significantly higher than that in the control group, 
and the number of CD3+CD8+CD57+ cells was relatively higher 
compared to the control group. The number of CD3+CD4+CCR7+ 
T cells in the patients was significantly lower compared to the control 
but in the CD8 subgroup, no significant difference was observed.
Regarding the significant decrease in the number of lymphocytes 
in the patients compared to the control, we investigated the effect 
of age, ferritin, blood transfusion, and desferal infusion level on 
the number of T lymphocytes; the changes in none of them were 
significantly correlated with the number of T cells.
A correlation between Ferritin level and t cell 
Subtypes 
The effect of age, ferritin level, the amount of blood transfusion, and 
desferal infusion level on the number of the cells representing each 
one of the investigated lymphocyte markers was also examined 
[Table/Fig-5]. 
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No significant difference was observed in the ferritin level between 
the splenectomized and unsplenectomized patients (1487±995.85 
vs. 1565±956 ng/dl). The number of CD3+CD8+CD27+ cells was 
inversely correlated with ferritin level (p < 0.01), while there was no 
correlation between this cell population and age, blood transfusion, 
and desferal infusion level. However, the percentage of these cells 
was significantly and inversely correlated with total blood transfusion 
and desferal infusion level (p = 0.03 and p = 0.02, respectively, data 
not shown in Table). The number of CD3+CD4+CD27+ lymphocytes 
was not correlated with age, blood transfusion, and ferritin level; 
however, the percentage of CD3+CD8+CD27+ cells was inversely 
correlated with the blood transfusion and desferal infusion level, as 
well (p = 0.04 and p = 0.02 respectively, the data not shown in 
Table).
The number of CD3+CD4+CD57+ lymphocytes was positively 
correlated with ferritin level [Table/Fig-6], while there was no 
correlation of this cell population with age, blood transfusion, 
and desferal infusion level. The number of CD3+CD8+CD57+ 
lymphocytes was also positively correlated with ferritin (p=0.003), 
but not with age, blood transfusion and desferal infusion level [Table/
Fig-5,6].
The number of CD3+CD8+CCR7+ cells was significantly correlated 
with ferritin level, while this cell population had no significant 
correlation with age, blood transfusion, and desferal infusion level. 
The number of CD3+CD4+CCR7+ cells was significantly correlated 
with none of the above variables, as well. CD28 expression in 
neither of the subgroups of CD4 and CD8 T cells was significantly 
correlated with the studied variables except for desferal infusion 
level with a positive correlation.
dIScuSSIOn
Immunologic disorders in the patients with beta-thalassaemia major 
including non-specific immune response, lymphocyte subsets and 
changes in cytokines production have already been reported [7]. 
The mechanism of these disorders has not been clearly explained, 
but it could be related to iron overload, repeated blood transfusions, 
allogeneic stimulation and iron chelation therapy [14,16,17]. The 
significant increase in lymphocyte number is related to B cells 
number, which could be due to repeated blood transfusions. In our 
study CD4/CD8 ratio did not change significantly compared to the 
control group, which is consistent with the study conducted by by 
Al-Awadhi et al., [18]; however, in other studies an inversed ratio 
has been reported. Since the patients in our study were hepatitis 
B and C negative, normal CD4/CD8 ratio could be to some extent 
explained. 
In investigating the correlation between the number of T lymphocytes 
and the patient’s age, ferritin level, blood transfusion, and desferal 
infusion level, no significant correlation was observed. Since CD3+ 
T cells have qualitative and quantitative changes in spelenectomized 
patients and 12 patients were splenectomized, the role of other 
factors could be moderated [19].
One of the findings in the present study is the moderate change in 
CD27 expression on T lymphocyte surface. Effector memory cells 
are CD27-, and in elderly people the decrease in CD27- expression 
on T lymphocytes surface has been noted [20]; in addition, the 
cells with a large amount of CD27 were not found among the virus-
specific lymphocytes [21], which indicates these lymphocytes have 
lost the marker after stimulation. Both groups of effector memory 
cells, i.e. CD45RO+ and CD45RA+, are CD27- [22]. In B cells, the 
subgroup of IgD-CD27- lymphocytes increases as age advances 
[23]. In the study conducted by Albareda et al. a high proportion of 
CD45RA-CD27-CD28- was observed in the patients infected with 
tripanozome [24]. The HIV-infected patients with a higher dose of 
virus have a larger cell population of CD27-CCR7-CD45RO+ [25] 
In all these studies, chronic contact with antigen has negatively 
affected CD27 expression on lymphocytes surface and in our study 
expression rate of this molecule in the patients in both CD4 and 
CD8 populations was less than that in the control group, although 
the differences were not significant. The moderation of these 
changes could be related to the negativity of hepatitis B and C in 
these patients. Regarding limited number of the patients under our 
study, further research may be required.
No significant correlation was observed between the number of 
lymphocytes expressing CD27 and age, blood transfusion and 
desferal infusion level in CD4+ T cells, but the percentage of 
lymphocytes expressing CD27 was inversely correlated with blood 
transfusion and desferal infusion level. In CD8+ T cells, a negative 
correlation was observed with transfusion rate and ferritin level. Since 
contact with antigens increases as blood transfusion increases, 
these findings are not surprising. As transfusion of each blood unit 
could expose immune system to allogeneic antigens, it could be 
related to the moderate decrease in CD3+CD27+ lymphocytes. 
Increased ferritin level is correlated with iron overload in these 
patients and could affect immune system function adversely.
The number of CD3+CD4+CCR7+ lymphocytes in the control group 
was significantly higher than that of the patients. The expression 
of this marker is used to discriminate between naïve and central 
memory cells, and effectors memory cells [13]. The latter population 
is basically CCR7- [26]. The HIV-infected patients with high viral set 
point possessed significantly higher frequency of CCR7- T cells [25]. 
Less expression of this marker on CD4+ T cells in our patients could 
represent the decline in naïve and central memory versus effector 
memory (effector memory and terminally differentiated effector 
memory) T cells in these patients.
Another phenotypic index, CD57, significantly increased in the 
patients compared to the control group, was observed in both 
CD4+ and CD8+ T cells, but significant for CD4+ subgroup and 
partially significant for CD8+ T cells. This marker is a glycoprotein 
whose increase has been noted on the elderly’s T cells [27]. 
CD3+CD57+ cells are more sensitive to activation-induced cell 
apoptosis [9]. CD8+CD57+CD28- cells have a limited or no ability 
to proliferate; however, it has been challenged by some studies. 
They express that these cells are not completely scenescent and 
[table/Fig-6]: a) A positive correlation was observed between the frequency 
of CD4+CD57+ T cells and ferritin level; b) A positive correlation was observed 
between the frequency of CD8+CD57+ T cells and ferritin level.
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could proliferate while influenced by specific stimuli. Strioga et 
al., concluded that CD8+CD28-CD27- (CD8+CD57+CD27-) cells 
were closer to terminal differentiation and replicative senescence 
than CD8+CD57+CD27+ cells [9]. Increased proportion of CD57+ 
T cells in the peripheral blood of the patients with progressive 
gastric carcinoma has been associated with poor prognosis 
[28]. Expression of CD8+CD57+ T cells has been suggested as 
a diagnostic tool in the patients with an organomegally or organ 
infiltration [29]. Proportion of CD4+CD57+ T cells has been 
correlated with tumour progresssion and inversely correlated with 
IFNγ production in hepatocarcinoma patients [30]. The increased 
number of this population in our patients may be a feature of 
early immunosenescence. The correlation between the number of 
CD4+CD57+ T cells and ferritin level could explain the effect of iron 
overload on T lymphocyte subpopulations.
cOncluSIOn 
The results indicated that the patients with thalassaemia major 
who are hepatitis B, hepatitis C, and HIV negative had some 
changes in T lymphocytes. The moderate increase in subgroups 
of CD3+CD27-, CD3+CCR7-, and CD3+CD57+ cells could 
reflect nonspecific stimulation as well as the iron overload effect, 
potentially explained by negative correlation of blood transfusion 
and ferritin level with CD3+CD27- frequency as well as ferritin with 
CD3+CD57+ frequency. If the blood products containing younger 
red cells are used and consequently the need for blood transfusion 
and chelation therapy declines, early immunosenescence can be 
largely prevented in these patients. The new approaches to iron 
chelation like deferiprone should be further investigated. Since 
the present study was conducted on the patients over 10 years, 
study of younger patients is also needed to further investigate these 
changes and early immunosenescence. Moreover, investigating 
other immunosenescence-related alterations in these patients is 
suggested.
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